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Abstract. 
 
We have identified CALNUC, an EF-hand, 
 
Ca
 
2
 
1
 
-binding protein, as a Golgi resident protein. 
CALNUC corresponds to a previously identified EF-
hand/calcium-binding protein known as nucleobindin. 
CALNUC interacts with G
 
a
 
i3
 
 subunits in the yeast two-
hybrid system and in GST-CALNUC pull-down assays. 
Analysis of deletion mutants demonstrated that the 
EF-hand and intervening acidic regions are the site of 
CALNUC’s interaction with G
 
a
 
i3
 
. CALNUC is found 
in both cytosolic and membrane fractions. The mem-
brane pool is tightly associated with the luminal surface 
of Golgi membranes. CALNUC is widely expressed, as 
it is detected by immunofluorescence in the Golgi re-
gion of all tissues and cell lines examined. By immuno-
electron microscopy, CALNUC is localized to 
 
cis-
 
Golgi 
cisternae and the 
 
cis-
 
Golgi network (CGN). CALNUC 
is the major Ca
 
2
 
1
 
-binding protein detected by 
 
45
 
Ca
 
2
 
1
 
-
binding assay on Golgi fractions. The properties of 
CALNUC and its high homology to calreticulin suggest 
that it may play a key role in calcium homeostasis in the 
CGN and 
 
cis
 
-Golgi cisternae.
 
T
 
he
 
 ER is well known to constitute a major storage
compartment for intracellular Ca
 
2
 
1
 
 that upon ap-
propriate signaling is released into the cytosol and
plays a fundamental role in cell physiology. In addition to
its role in signaling, it has become evident that Ca
 
2
 
1
 
 is also
essential for many functions that take place within com-
partments of the exocytic pathway. For example, it is re-
quired for chaperone functions and quality control in the
ER (Booth and Koch, 1989; Lodish and Kong, 1990; Sam-
brook, 1990; Lodish et al., 1992) and concentration and
proteolytic processing of secretory proteins within regu-
lated secretory granules (Chanat and Huttner, 1991; Car-
nell and Moore, 1994; Canaff and Brechler, 1996). The
Golgi region has also been identified as a Ca
 
2
 
1
 
-enriched
compartment based on ion microscopy (Chandra et al.,
1991; Zha and Morrison, 1995). Recently, it has been dem-
onstrated directly by electron energy loss spectroscopy
(EELS),
 
1
 
 a new technique that allows high resolution cal-
cium mapping of intracellular compartments (Grohovaz
et al., 1996), that Golgi cisternae have a high Ca
 
2
 
1
 
 level ex-
tending across the entire 
 
cis
 
-
 
trans
 
 axis of the Golgi (Pez-
zati et al., 1997). The question is how is this high Ca
 
2
 
1
 
 con-
centration maintained in the Golgi? In the case of the ER,
Ca
 
2
 
1
 
 storage is believed to be maintained by multiple cal-
cium-binding proteins including calnexin, calreticulin,
GRP78 (BiP), GRP94, ERp72, protein disulfide isomerase,
reticulocalbin, and ERC55 (Pozzan et al., 1994; Meldolesi
and Pozzan, 1998) of which the most important appears to
be calreticulin (Mery et al., 1996). Much less is known
about the internal milieu of the Golgi. To date, only a sin-
gle Golgi luminal Ca
 
2
 
1
 
-binding protein has been identi-
fied, Cab45, which, interestingly, has high homology to the
ER Ca
 
2
 
1
 
-binding proteins reticulocalbin and ERC55
(Scherer et al., 1996).
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1. 
 
Abbreviations used in this paper
 
: 
 
a
 
-Man II, 
 
a
 
-Mannosidase II; 
 
b
 
-gal,
 
b
 
-galactosidase; aa, amino acids; CGN, 
 
cis
 
-Golgi network; CHX, cyclo-
heximide, CRT, calreticulin; CV, carrier vesicle fraction; Cyt, cytosol;
EELS, electron energy loss spectroscopy; ERGIC, ER–Golgi intermedi-
ate compartment; GAP, GTPase-activating protein; GH, Golgi heavy;
GL, Golgi light; GDT, glutathione-
 
S
 
-transferase; NLS, nuclear localiza-
tion signal; PFA, paraformaldehyde; PK, proteinase K; PNS, postnuclear
supernatant; PVDF, polyvinylidene difluoride; RM, residual microsomes;
TBS-T, TBS–0.05% Tween; TM, total membranes.
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In this paper we have identified a second Golgi Ca
 
2
 
1
 
-
binding protein which we call CALNUC with significant
sequence homology to another ER Ca
 
2
 
1
 
-binding protein,
calreticulin. We identified CALNUC in a yeast two-hybrid
screen using the heterotrimeric G protein G
 
a
 
i3
 
 as bait.
CALNUC corresponds to a known protein called nucle-
obindin (Miura et al., 1992; Wendel et al., 1995). Nucle-
obindin was thought to be a transcription factor based on
its ability to bind DNA fragments in vitro, thus the name
nucleobindin (Miura et al., 1992). Nucleobindin was first
identified in culture supernatant of a B lymphocyte cell
line established from mice prone to the autoimmune disor-
der, systemic lupus erythematosis (Kanai et al., 1986; Mi-
ura et al., 1992), and was later isolated as a minor protein
constituent from bone extracellular matrix (Wendel et al.,
1995). Recombinant nucleobindin was also shown to bind
Ca
 
2
 
1
 
, and the first of its two EF hands was required for
binding (Miura et al., 1994). The localization of nucleobin-
din has been problematic. It has been variously suggested
to be a nuclear protein (Wang et al., 1994), a secreted pro-
tein (Miura et al., 1992; Wendel et al., 1995), and a resi-
dent ER protein, the latter based on its interaction with
the cyclooxygenase isoenzymes 1 and 2 (Ballif et al., 1996).
Because of the intriguing diverse properties of this mol-
ecule, such as the EF-hand/calcium–binding domains, its
homology to calreticulin, and its ability to interact with the
G
 
a
 
i
 
 subfamily of heterotrimeric G proteins (Mochizuki
et al., 1995), we set out to characterize nucleobindin, here-
after referred to as CALNUC, and especially to define its
localization in the hope of shedding light on its function.
To our surprise, we found CALNUC both in cytosolic
fractions and associated with Golgi membranes. The
Golgi-associated form proved to be a Golgi resident pro-
tein concentrated in the 
 
cis
 
-Golgi network (CGN) and 
 
cis
 
-
Golgi cisternae facing the Golgi lumen.
 
Materials and Methods
 
Antibodies
 
Rabbit antiserum raised against the rat homologue of nucleobindin (cal-
varia calcium-binding protein) was obtained from D. Heinegard (Univer-
sity of Lund, Sweden; Wendel et al., 1995). Rabbit antisera to GM130
(Nakamura et al., 1995), 
 
a
 
-adaptin, calnexin (Wada et al., 1991), and
TGN38 were obtained, respectively, from Drs. Graham Warren (Imperial
Cancer Research Foundation, London, UK), S. Schmid (Scripps Research
Institute, La Jolla, CA), J.J.M. Bergeron (McGill University, Montréal,
Canada), and G. Banting (University of Bristol, UK). Rabbit antiserum to
 
a
 
-Mannosidase II (
 
a
 
-Man II) was prepared as described (Velasco et al.,
1993) and mouse mAb 53FC3 against 
 
a
 
-Man II was obtained from Dr.
Brian Burke (Burke et al., 1982; University of Alberta, Canada). Affinity-
purified anti–
 
b
 
-COP IgG, raised against the EAGE peptide (Duden et al.,
1991) was characterized earlier (Hendricks et al., 1993). mAb G1/93
against ERGIC-53 was provided by Dr. H.-P. Hauri (Biozentrum, Univer-
sity of Basel, Switzerland).
 
Construction of the Rat GC Cell Library and Yeast 
Two-Hybrid Screening
 
Double stranded cDNA was generated from 7 
 
m
 
g poly(A)
 
1
 
 RNA isolated
from rat GC pituitary cells (subcloned from GH
 
3
 
 cells) using a random
primed cDNA synthesis kit (Stratagene, Inc., San Diego, CA). EcoRI and
XhoI oligo synthesized adapter linkers were ligated onto the cDNA at the
5
 
9
 
 and 3
 
9
 
 end, respectively, and the library was inserted into the Gal4 acti-
vation domain pACT2 “prey” vector (CLONTECH Laboratories, Palo
Alto, CA). The total library contains 
 
z
 
2 
 
3
 
 10
 
6
 
 independent clones.
 
The complete rat cDNA of G
 
a
 
i3
 
 was cloned into the Gal4 DNA-bind-
ing domain pGBT9 “bait” vector (CLONTECH Laboratories) as de-
scribed (De Vries et al., 1995). The pGBT9G
 
a
 
i3
 
 “bait” vector was trans-
formed into yeast strain HF7c (CLONTECH Laboratories). The
transformed yeast colonies were selected on tryptophan (
 
2
 
Trp) selective
plates, and after 6 d the plasmids from surviving colonies were analyzed
for the presence of pGBT9G
 
a
 
i3
 
.
For interaction screening in the yeast two-hybrid system (Chien et al.,
1991), 50 
 
m
 
g of the rat GC-cell cDNA library in the pACT2 vector was
transformed into yeast HF7c(pGBT9G
 
a
 
i3
 
) strain (Schiestl and Gietz,
1989). Approximately
 
 
 
10
 
6
 
 colonies were plated onto selective medium,
and colonies that survived were scored for 
 
b
 
-galactosidase (
 
b
 
-gal) activity
by a colony lift assay (CLONTECH Laboratories). Plasmid DNA from
the HIS
 
1
 
/
 
b
 
-gal
 
1
 
 colonies was purified by transforming into 
 
Escherichia
coli
 
 HB101 by electroporation. These plasmids were retransformed into
the HF7c strain alone or with various control plasmids, including the orig-
inal pGBT9G
 
a
 
i3
 
 “bait” plasmid. Positive clones were grouped based on
restriction analysis, and 24 fragments of different sizes were selected and
sequenced from the 5
 
9
 
 or the 3
 
9
 
 end of the inserts by automated sequencing.
 
In Vivo Interactions
 
To construct a complete coding sequence of CALNUC, the insert of a
clone containing the 5
 
9
 
-end was ligated to the insert of a 3
 
9
 
-end via an in-
ternal EcoRI site, and the reconstituted full-length insert was ligated into
the pACT2 vector. Deletion mutants of CALNUC (CALNUC
 
227–372
 
,
CALNUC
 
320–372
 
, and CALNUC
 
227–320
 
) were generated by PCR using
CALNUC-specific primers (sequences available upon request), subcloned
into the pACT2 vector, and cotransformed with pGBT9G
 
a
 
i3
 
.
Full-length pACT2-CALNUC was cotransformed with the following
G
 
a
 
 subunits in pGBT9 vectors: rat G
 
a
 
i3 
 
(De Vries et al., 1995), rat G
 
a
 
i2
 
,
and mouse G
 
a
 
q
 
, (obtained from P. Insel, University of California San Di-
ego), rat G
 
a
 
i1
 
 (from T. Kosasa, University of Texas, Southwestern Medi-
cal Center, Dallas, TX), rat G
 
a
 
s
 
 (from H. Bourne, University of California
San Francisco), rat G
 
a
 
o
 
 from E. Neer (Brigham and Women’s Hospital,
Boston, MA), and rat G
 
a
 
z
 
, (from E. Ross, University of Texas, Southwest-
ern Medical Center). Interactions were analyzed qualitatively by a colony
lift assay for 
 
b
 
-gal using 5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
D
 
-galactoside
(Guarente, 1983).
Figure 1. Characterization of GST-CALNUC and affinity-puri-
fied anti-CALNUC IgG. (A) 5 ng purified GST-CALNUC was
separated by 10% SDS-PAGE, transferred to a PVDF mem-
brane, and immunoblotted with 0.67 mg/ml affinity-purified anti-
CALNUC IgG (lane 2) or preimmune serum (lane 1). The anti-
body was capable of detecting 5 ng GST-CALNUC (90 kD). (B)
PNS prepared from NRK cells (50 mg/lane) was immunoblotted
with 0.38 (lane 2) and 0.17 (lane 3) mg/ml affinity-purified anti-
CALNUC IgG or preimmune serum (lane 1). Endogenous CAL-
NUC (63 kD) could be detected with as little as 0.17 mg/ml of the
purified antibody. (C) 45Ca21-overlay. 50 mg GST (lane 1) or
GST-CALNUC (lane 2) was separated by SDS-PAGE, trans-
ferred to a PVDF membrane and overlaid with 4 mCi/ml 45CaCl2.
After exposure of the washed and dried membrane to Kodak
X-Omat AR film, a z90-kD signal that corresponds to the fusion
protein was detected. 
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Database Searches
 
Online BLAST searches were performed in the GenBank database (National
Institutes of Health, Bethesda, MD) via the National Center for Biotechnol-
ogy Information’s (NCBI) home page on the World Wide Web. PROSITE
(Geneworks; IntelliGenetics, San Francisco, CA), BLASTP and Psort were
used for protein analysis. To compare the primary structure of CALNUC,
calreticulin (CRT), and Cab45 their amino acid (aa) sequences were aligned
using GeneWorks 2.5.1 software (IntelliGenetics, San Francisco, CA).
 
Expression and Purification of
Glutathione-S-Transferase–CALNUC Fusion Protein
 
For the production of recombinant glutathione-
 
S
 
-transferase (GST) fu-
sion protein, CALNUC cDNA was subcloned into the pGEX-KG vector
(Pharmacia Biotechnology, Inc., Piscataway, NJ), and transformed into 
 
E.
coli
 
 (Y1090) cells. GST-CALNUC fusion protein was affinity purified
from bacterial lysates on glutathione–Sepharose and used for immuniza-
tion of rabbits, in vitro pull-down assays, and 
 
45
 
Ca
 
2
 
1
 
 overlay.
 
Preparation, Affinity Purification, and 
Characterization of Anti-CALNUC IgG
 
Antibodies were raised in rabbits against purified full-length GST-CAL-
NUC. For affinity purification, purified recombinant CALNUC was cou-
pled to cyanogen bromide-activated Sepharose 4B (Pharmacia Biotech-
nology, Inc.). Antibodies were then bound to the coupled beads and
eluted sequentially with 0.1 M glycine/HCl (pH 2.5) and 0.1 M triethy-
lamine (pH 11.5). The affinity-purified antibody recognized 5 ng recombi-
nant GST-CALNUC at a dilution of 0.67 
 
m
 
g/ml (see Fig. 1 
 
A
 
) and specifi-
 
cally recognized CALNUC in 50 
 
m
 
g NRK cell lysate at a concentration of
0.17 
 
m
 
g/ml (see Fig. 1 B).
45Ca21 Overlay
50 mg purified GST-CALNUC or 200 mg Golgi proteins were transferred
from SDS gels onto polyvinylidene difluoride (PVDF) membranes (Imo-
bilon P; Millipore Corp., Bedford, MA), followed by incubation of the mem-
branes with 45CaCl2 (Dupont-NEN, Boston, MA) as described (Maruyama
et al., 1984). The membranes were processed for autoradiography (Kodak
X-Omat Film or a PhosphorImager cassette). Quantitation of the bound
Ca21 was done by densitometry or by direct counting, respectively.
In Vitro Interactions
Wild-type rat Gai3 cDNA, activated rat Gai3(Q204L), and inactivated
Gai3(G203A) mutants, obtained from A. Spiegel (National Institutes of
Health, Bethesda, MD), were subcloned into pBluescript SK1 (Stratagene,
San Diego, CA). In vitro transcription/translation of the various forms of
Gai3 from the T7 promoter in pBluescript SK1 was performed using the
TNT-coupled reticulocyte lysate system (Promega Corp., Madison, WI) in
the presence of [35S]methionine (in vivo cell labeling grade; Amersham
Pharmacia Biotech Inc, Arlington Heights, IL) according to the manufac-
turer’s instructions. Purified GST-CALNUC fusion protein (6 mg) or GST
control (6 mg) was immobilized on glutathione–Sepharose beads and incu-
bated with 15,000 cpm 35S-labeled, in vitro-translated Gai3 (mutant or wild-
type) in binding buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 3 mM EDTA,
0.1% NP-40, 1 mM DTT, and protease inhibitors) as previously described
(Mochizuki et al., 1995). The mixture was incubated by rotating for 2 h at
48C. The beads were washed three times in the same binding buffer, resus-
pended in 25 ml of Laemmli buffer, boiled for 5 min, and then the proteins
were loaded on 10% SDS gels and exposed for autoradiography.
Figure 2. (A) Structure of
CALNUC. Rat CALNUC is
a 434-aa protein with an
NH2-terminal signal se-
quence, a putative DNA-
binding domain (BASIC
REGION) with a nuclear lo-
calization signal (NLS), an
acidic region flanked by two
EF-hand motifs (EF-1, EF-
2), and a leucine zipper mo-
tif. (B) aa 227–287 are re-
quired for interaction with
Gai3. Those deletion mutants
spanning aa 227–287 contain-
ing two EF-hands and a
central acidic region (CAL-
NUC227–372, CALNUC227–320)
bind to Gai3, whereas, mutants
that lack this region (CAL-
NUC287–434, CALNUC320–372)
do not. pGBT9Gai3 “bait”
vector was cotransformed with
various pACT2-CALNUC
mutants into yeast strain
HF7c. The transformed colo-
nies were scored for b-gal ac-
tivity by a colony lift assay.
(C) Verification of the site of
CALNUC’s interaction with
Gai3 by an in vitro binding
assay. [35S]Gai3 ( arrows)
binds to GST-CALNUC116–434
(lane 6), GST-CALNUC227–372
(lane 4), and GST-CALNUC227–320 (lane 3), but not to GST-CALNUC287-434 (lane 5), GST-CALNUC320–372 (lane 2), or to control beads
with GST alone (lane 1). GST-CALNUC fusion proteins bound to glutathione-agarose beads were incubated with 35S-labeled, in vitro
translated Gai3 for 2 h, the bound proteins were separated by 10% SDS-PAGE and detected by autoradiography.The Journal of Cell Biology, Volume 141, 1998 1518
Cell Culture
AtT-20/D-16v pituitary cells, obtained from Dr. Richard Mains (Johns
Hopkins University, Baltimore, MD), were maintained in DME medium
(high glucose) supplemented with 10% (vol/vol) horse serum 2.5% (vol/
vol) FCS (GIBCO BRL, Gaithersburg, MD). Normal rat kidney (NRK)
cells were grown in DME supplemented with 5% FCS, 2.5% Nu-IV serum
(Collaborative Research, Inc., Waltham, MA), and REF-52, HeLa, and
GC cells were maintained in 10% FCS in DME high glucose medium.
Vero cells were grown in MEM Earles in 10% FCS. PC12 cells (passage 6
to 20), originally obtained from Dr. L. Greene, were maintained in RPMI
1640 Medium (GIBCO BRL) supplemented with 10% heat-inactivated
horse serum, 5% FCS. All culture media contained 100 U/ml penicillin G
and 100 mg/ml streptomycin sulfate. Cells were used as confluent mono-
layers.
Immunocytochemistry
For immunofluorescence, cells were cultured on glass coverslips for 2–3 d,
fixed for 1 h with 2% paraformaldehyde (PFA) in 0.075 M phosphate
buffer, pH 7.4, and permeabilized with 0.1% Triton X-100 in PBS (10
min). They were then incubated for 1 h at room temperature with affinity-
purified rabbit antibodies to CALNUC or mouse mAb to ERGIC-53 or
Man II followed by crossed-absorbed FITC- or Texas red–conjugated
donkey anti–rabbit or anti–mouse F(ab9)2 (Jackson ImmunoResearch
Laboratories, West Grove, PA). For double labeling, cells were incubated
simultaneously with rabbit polyclonal anti-CALNUC and mouse mAb
ERGIC-53 or Man II followed by incubation with appropriate anti-rabbit
and anti-mouse conjugates. Cells were mounted in 25% PBS, 75% glyc-
erol with 1 mg/ml r-phenylinediamine, and then examined with a Zeiss
Axiophot equipped for epifluorescence (Carl Zeiss Inc., Thornwood, NY).
For immunogold labeling, cultured cells were fixed in 8% PFA, 100
mM phosphate buffer, pH 7.4 (15 min), followed by 4% PFA in phosphate
buffer (1 h). Samples were then cryoprotected and frozen in liquid nitro-
gen as described earlier (McCaffery and Farquhar, 1995). Ultrathin cryo-
sections were prepared and incubated with primary antibodies in 10%
FCS/PBS for 2 h at room temperature followed by incubation in 5 or 10 nm
gold, goat anti–rabbit or anti–mouse IgG conjugates (Amersham Pharma-
cia Biotech Inc.) for 1 h at room temperature. Sections were post-fixed (10
min) with 2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, stained
for 30 min in 2% uranyl acetate, adsorption stained for 10 min with 0.2%
uranyl acetate, 0.2% methyl-cellulose, and 3.2% polyvinyl alcohol and
then examined in a Philips CM10 or a JEOL 1200EX II electron micro-
scope. For immunofluorescence, semithin cryosections (0.5–1.0 mm) were
incubated as above except that incubation in primary antibodies was for 2 h
at room temperature. For immunofluorescence and immunogold labeling
of pituitary, liver, and kidney tissue, organs were perfusion-fixed with PLP
fixative (2% paraformaldehyde, 0.75 M lysine, 0.01 M sodium periodate in
0.1 M phosphate buffer, pH 6.2; McLean and Nakane, 1973) and pro-
cessed as described for cultured cells.
Preparation and Treatments of Membrane Fractions 
from Cultured Cells
Cells were washed twice with cold PBS and subsequently scraped into ho-
mogenization buffer containing protease inhibitors (0.5 mg/ml aprotinin,
0.5 mg/ml pepstatin A, 0.2 mg/ml leupeptin, 1 mM 4-(2-aminoethyl)-ben-
zenesulfonyl-fluoride hydrochloride; ICN Biomedicals, Costa Mesa, CA),
and 5 mM EDTA in TBS. They were then gently homogenized by 10 pas-
sages through a 28 1/2-G needle and nuclei and unbroken cells were re-
moved by centrifugation (600 g for 3 min). Membrane pellets were pre-
pared by centrifugation of the postnuclear supernatant (PNS) at 100,000 g
for 1 h at 48C in a Beckman TL-100 ultracentrifuge (Beckman Instru-
ments., Inc., Fullerton, CA). The protein concentration of the membrane
pellets was obtained by BCA assay (Pierce Chemical Co., Rockford, IL).
Figure 3. Sequence compari-
son of rat and mouse CAL-
NUC, and rat, human, and
bovine CRT (isoform-1 and
-2). CALNUC shares signifi-
cant sequence homology to
the P-domain (rat CRT238–297)
and C-domain (rat CRT298–416)
of CRT. Regions of aa iden-
tity are boxed and regions of
aa similarity are shaded. EF-
hand loop structures in CAL-
NUC are indicated above
(upper line). Two conserved
sequences AY(I/A)EE and
QRLX(Q/E)E(I/E)E, found
in both CALNUC and CRT,
are underlined.
Table I. Interaction between CALNUC and Ga Subunits in 
Yeast Two Hybrid Filter Assay
Bait b-gal Filter
Gai3 111
Gai3 (Q204L) 111
Gai3 (G203A) 111
Gai1 111
Gai2 11
Gao1 1
Gaz 11
Gas 11
Gaq —
Ga12 —
Ga13 —
The b-gal filter assay was performed on (Leu2, Trp2) plates, and the color intensity
was scored after 8 h. 2, no color; 1, weak color; 11, intermediate color, 111,
strong color. Baits were constructed in pGBT9, and CALNUC prey vector was
pACT2-CALNUC.Lin et al. GALNUC Is a Golgi Resident Protein 1519
For digestion with proteinase K (PK), membranes (100 mg) were sus-
pended in 200 ml of reaction buffer containing 10 mM Tris-HCl (pH 7.8),
150 mM KCl, 2 mM MgCl2, 2 mM CaCl2, and 0.2 M sucrose followed by
incubation with 10 or 20 mg of PK (Boehringer Mannheim GmbH, Mann-
heim, Germany) at room temperature for 30 min, after which 10 mM
PMSF was added to stop the reaction. Proteins were separated by SDS-
PAGE and immunoblotted with appropriate antibodies.
For alkaline extraction, membranes (100 mg) were suspended in 200
ml–0.2 M Na2CO3 (pH 11.5; Fujiki et al., 1982) containing protease inhibi-
tors, incubated on ice for 30 min, and centrifuged at 100,000 g for 1 h at
48C. Supernatants were kept on ice for later use, and pellets were resus-
pended in 200 ml–0.2 M Na2CO3 (pH 11.5), followed by SDS-PAGE and
immunoblotting.
Triton X-114 extraction was carried out essentially as described earlier
(Bordier, 1991) except that proteins in the aqueous and detergent phases
were precipitated with 10% TCA for 30 min on ice followed by SDS-
PAGE and immunoblotting.
Preparation of Rat Liver Golgi Fractions
Rat liver fractions were prepared by density gradient centrifugation and
characterized as described previously (Saucan and Palade, 1994; Jin et al.,
Figure 4. CALNUC is localized by immunofluorescence in the Golgi region in cultured cells. CALNUC is found in the Golgi region (ar-
rows) in NRK, PC-12, and HeLa cells where it partially overlaps with the Golgi marker, a-Man II, and cis-Golgi/ERGIC marker, ER-
GIC-53. Cells were fixed in 2% paraformaldehyde in phosphate buffer, permeabilized, and doubly incubated with affinity-purified rab-
bit polyclonal CALNUC antibody (5 mg/ml) and mouse mAb Man II or ERGIC-53 followed by cross-absorbed Texas red–conjugated
donkey anti–rabbit and FITC-conjugated donkey anti–mouse F(ab9)2. Bar, 10 mm.The Journal of Cell Biology, Volume 141, 1998 1520
1996). In brief, total microsomes were adjusted to 1.24 M sucrose, loaded
onto the bottom of a discontinuous sucrose gradient, and then centrifuged
at 82,000 g. All procedures were done at 48C in the presence of protease
inhibitors. The resulting fractions were designated as Golgi light (GL) and
Golgi heavy (GH), enriched in Golgi elements, carrier vesicle fractions 1
and 2 (CV1 and CV2), enriched in transport vesicles, and residual mi-
crosomes (RM). The protein concentration of each fraction was deter-
mined by BCA assay (Bio-Rad Laboratories, Hercules, CA). Fractions
were then treated with PK, alkaline pH (11.5), or Triton X-114 essentially
as described for membranes from cultured cells except that the Na2CO3-
extracted samples were loaded on the top of a 6% sucrose cushion and
centrifuged at 400,000 g for 25 min. The supernatants were collected and
Golgi membrane pellets were resuspended in Tris-EDTA (10 mM Tris,
pH 7.5, 1 mM EDTA) and processed for SDS-PAGE and immunoblotting.
For some experiments liver fractionation was carried out by the
method of Leelavathi et al. (1970) as modified by Taylor et al. (1997). In
brief, livers of Sprague-Dawley rats were perfused with 20 ml 6% (wt/vol)
sucrose in 100 mM KH2PO4/KHPO4, pH 6.8, 5 mM MgCl2 buffer with
protease inhibitors, homogenized in the perfusion buffer using a glass/te-
flon homogenizer and spun at 1,500 g for 10 min. The PNS was loaded
onto a discontinuous sucrose gradient (1.3 M, 0.86 M sucrose, PNS, 0.25 M
sucrose, 6 ml each) in a SW28 tube (Beckman Instruments., Inc.), centri-
fuged at 100,000 g for 90 min, and crude fractions designated SI, SII, and
SIII were isolated with disposable syringes from the PNS/0.25 M sucrose,
0.86 M sucrose/PNS, and 1.3 M sucrose/0.86 M sucrose interphases, re-
spectively. To prepare Golgi fractions depleted of cargo, rats were in-
jected with 1.5 mg cycloheximide in 150 mM NaCl per kg body weight
through the tail vein 90 min before liver excision (Taylor et al., 1997).
Fractions were processed for 45Ca21 overlay or immunoblotting.
SDS-PAGE and Immunoblotting
Proteins were separated on 10% SDS gels under reducing conditions, fol-
lowed by transfer to PVDF membranes (Millipore Corp.). Membranes
were blocked with 5% nonfat dry milk in TBS–0.05% Tween (TBS-T) and
blotted with primary antibodies followed by incubation with HRP conju-
gated goat anti–rabbit IgG (1:3,000 in TBS-T), secondary antibody (Bio-
Rad Laboratories), and detection by ECL (Pierce Chemical Co.). Quanti-
tation of protein bands was done by densitometry using ScanAnalysis
Software (Biosoft, Cambridge, UK).
Results
Identification of CALNUC as a Ca21-binding Protein 
that Interacts with Gai3
To search for protein(s) that can interact with the hetero-
trimeric G-protein, Gai3, we used the yeast two-hybrid sys-
tem to screen a rat GC cell pituitary library and isolated 24
inserts of different sizes that were sequenced and ana-
lyzed. 3 out of the 24 clones sequenced were identified as
the rat homologue of human GAIP, a GTPase-activating
protein (GAP) identified earlier (De Vries et al., 1995,
1996, 1998), 8 contained novel sequences, and 13 were
identified as the rat calvaria calcium-binding protein
(Wendel et al., 1995), the rat homologue of human nucle-
obindin (Miura et al., 1992). Using the BLAST program
the sequence we obtained was found to match 100% the
rat calvaria calcium-binding protein. Moreover, antibodies
raised against the latter protein (Wendel et al., 1995) rec-
ognized GST-CALNUC, and GST-CALNUC was found
to bind Ca21 in a 45Ca21-overlay (Fig. 1 C). Important fea-
tures of CALNUC are its signal sequence, two EF-hands
with an intervening acidic region, leucine zipper, and basic
region with a putative nuclear localization signal (NLS;
Fig. 2 A). CALNUC lacks a putative transmembrane
domain, but examination of its hydrophobicity using the
GeneWorks 2.5.1. program revealed a 15-aa hydrophobic
region at its COOH terminus.
Homology between CALNUC and Calreticulin
Among the known calcium-binding proteins CALNUC
was found to have 30% homology with rat CRT. The se-
quence similarity between rat, human, and bovine CRT
and rat and mouse CALNUC was found throughout the
two proteins, but it was highest in the P-domain (rat
CRT198–297) and C-domain (rat CRT298–416) where it was 36
and 43%, respectively (Fig. 3), and lower (26%) in the
N-domain (rat CRT1–197). Interestingly, the P- and C-domains
of CRT are thought to contain, respectively, high affinity
and low affinity Ca21-binding sites. Three helix-loop-helix
motifs (Type A repeats; Baksh and Michalak, 1996) that
are similar to the EF-hand motif in CALNUC (Fig. 3) are
found in the P-domain of CRT. The COOH-terminal re-
gion of CALNUC, like that of CRT, is also relatively
acidic. Since the acidic segments of the C-domain of CRT
were reported to represent low affinity, high capacity cal-
cium-binding sites, the same may apply to CALNUC.
Thus, the structure of CALNUC suggests that the COOH-
terminal region may have low affinity, high-capacity binding
sites at CALNUC343–352 and putative higher affinity-bind-
ing sites at the sites of the EF-hand motifs. There are also
notable differences between the structure of CALNUC
and CRT. For example, the three times repeated NPD/E
motifs in the P-domain of CRT and the conserved
KPEDWD motif found in both CRT and calnexin (Nash
et al., 1994) are not found in CALNUC. The COOH-ter-
minal KDEL ER retention signal found in CRT is also ab-
sent from CALNUC which is consistent with our finding
Figure 5. Localization of CALNUC to the
Golgi region in pituitary cells. (A) AtT-20
cells, prepared as in Fig. 4, showing CAL-
NUC concentrated in the Golgi region near
the nucleus (arrows). (B and C) Semithin sec-
tion of rat pituitary showing phase contrast
(B) and immunofluorescence localization
(C) of CALNUC in the Golgi region (arrows)
of several somatotrophs (ST) as well as other
cell types. Preparation was the same as in Fig.
4 except that fixation was by perfusion with
PLP. Bar, 10 mm.Lin et al. GALNUC Is a Golgi Resident Protein 1521
(see below) that the membrane-associated pool of CAL-
NUC resides in the Golgi, not the ER.
Another striking feature of unknown significance shared
by CALNUC and CRT are two short conserved aa se-
quences, AY(I/A)EE and QRLX(Q/E)E(I/E)E, found in
the C-domain of CRT (rat CRT337–341 and rat CRT365–372).
Further investigation is required to determine the func-
tions of these domains.
When the sequences of CALNUC and Cab45 were com-
pared, they also showed z30% similarity throughout, but
no striking homology was found except for a short aa se-
quence AANXE(E/D) identified in both Cab45 (aa 47–52
and CALNUC (aa 73–78).
The Two EF-Hand Motifs of CALNUC and Intervening 
Acidic Region Are Required for Interaction with Gai3
Analysis of the CALNUC clones isolated from the yeast
two-hybrid screen revealed that the smallest clone that in-
teracted with Gai3 was CALNUC227–434 (Fig. 2 B). The fact
that the clone that coded for CALNUC227–434 interacted
but CALNUC287–434 did not points to the importance of aa
227–287, the region containing the two EF-hands, for
binding. To further analyze the Gai3-binding domain sev-
eral deletion mutants, i.e., CALNUC227–372, CALNUC320–372,
and CALNUC227–320, were generated and their ability to
interact with Gai3 assessed in the yeast two-hybrid system.
The smallest mutant capable of binding Gai3 was CAL-
NUC227–320. Once again, this deletion mutant includes both
EF-hands and the intervening acidic region. The leucine
zipper region, aa 320–372, does not appear to be required
because CALNUC227–320 interacted with Gai3, but CAL-
NUC320–372 did not. From these data we conclude that the
two EF-hands and intervening acidic region constitute the
site of CALNUC’s interaction with Gai3.
Similar results were obtained using an in vitro binding
assay in which 35S-labeled, in vitro–translated Gai3 was in-
cubated with full-length or truncated GST-CALNUC fu-
sion proteins bound to glutathione-agarose beads: Gai3
bound to all GST-CALNUC fragments containing aa 227–
287, but not to those lacking this region (Fig. 2 C). Thus,
our results demonstrate by two different assays that the re-
gion that spans aa 227–287 containing the two EF-hand
motifs and intervening acidic aa-rich region, is required for
interaction with Gai3.
CALNUC Interacts with the Gai and Gas Family of Ga
We also used the two-hybrid system to test whether CAL-
NUC interacts with other Ga family members. As shown
in Table I, CALNUC interacted with all members of the
Gai subfamily (Gai1, Gai2, Gao1, and Gaz) as well as Gas,
but not with Gaq, Ga12, or Ga13. Based on the semi-quan-
titative b-gal filter assay, the strongest interaction was with
Gai3 and Gai1 and interactions with Gas and the other Gai
members were weaker. These results suggest that CAL-
Figure 6. Localization of CALNUC to Golgi cisternae in NRK
cells. Gold particles are found largely or exclusively on 1–2 cister-
nae (Gc) on one side of the Golgi stack (arrowheads). Typically,
.80% of the label is on the side facing the nucleus (n) assumed
to be the cis side of the Golgi stack. Cells were fixed in 8% para-
formaldehyde (PFA; 15 min) and 4% PFA (1 h). Ultrathin cryo-
sections were prepared and incubated sequentially with affinity-
purified anti-CALNUC IgG and 5- or 10-nm colloidal gold conju-
gated to goat anti–rabbit IgG. Sections were postfixed and
stained as described in Materials and Methods. Bar, 0.1 mm.The Journal of Cell Biology, Volume 141, 1998 1522Lin et al. GALNUC Is a Golgi Resident Protein 1523
NUC specifically interacts with members of the Gai and
Gs subfamily of heterotrimeric G proteins.
We further investigated whether the interaction be-
tween Gai3 and CALNUC is nucleotide-dependent using
the activated GTP-bound mutant, Gai3(Q204L), and inac-
tivated, GDP-bound mutant Gai3(G203A), and found that
both mutants bind to CALNUC as efficiently as wild-type
Gai3 (Table I).
CALNUC Is Localized to the Golgi Region
by Immunofluorescence
To determine the intracellular distribution of CALNUC
we carried out immunofluorescence on a number of rat
(GC pituitary cells, PC-12 cells, NRK cells, REF52 fibro-
blasts), mouse (AtT-20 pituitary cells), human (HeLa),
and monkey (Vero) cell lines. To our surprise, we found
that in all cells examined, CALNUC was localized to the
Golgi region (Figs. 4 and 5 A). After double labeling
CALNUC staining partially overlapped with both a-Man
II, a Golgi marker, and ERGIC-53, a marker for the ER–
Golgi intermediate compartment (ERGIC) and CGN
(Fig. 4). We also checked CALNUC’s distribution by im-
munofluorescence in semithin cryosections of rat pituitary
(Fig. 5, B and C), liver, and kidney. Again, in all cases
CALNUC was localized to the Golgi region. Staining was
very similar regardless of whether we used the antiserum
made against the native protein, provided by D. Heine-
gard (Wendel et al., 1995), or the affinity-purified IgG we
made against recombinant GST-CALNUC. In some cases
(e.g., rat kidney) variable cytoplasmic staining was ob-
served, but the predominant signal was in the Golgi re-
gion. CALNUC staining in the Golgi persisted in cells
treated for 3 h with cycloheximide (data not shown).
CALNUC Is Localized on Golgi Cisternae 
Concentrated on the Cis Side of the Golgi Stack
To determine whether CALNUC is associated with Golgi
membranes or with other organelles located in the Golgi
region we carried out immunogold labeling on ultrathin
cryosections of AtT-20 and NRK cells (Fig. 6) and rat an-
terior pituitary (Fig. 7), kidney, and liver tissue. In all
cases, labeling was concentrated on membranes of the
stacked Golgi cisternae and associated vesicles and was
more concentrated on cisternae and vesicles located on
one side of the Golgi stack. The latter could be identified
as the cis side based on the location of secretion granules
(Fig. 7, A and B) and on double labeling with TGN38 (Fig.
7 C). TGN38 was clearly distributed on the opposite or
trans side of the Golgi stack (Fig. 7 C). Counts of gold par-
ticles found on Golgi membranes after staining for CAL-
NUC indicate that .80% of the gold particles were found
on the one to two cis-most Golgi cisternae and associated
vesicles that together constitute the cis-Golgi network
(CGN; Farquhar and Hauri, 1997). Therefore, the immu-
nocytochemical findings indicate that CALNUC is associ-
ated with cis-Golgi cisternae and the CGN.
CALNUC Is Found in Both Membrane and
Cytosolic Fractions
The results of immunofluorescence and immunogold la-
beling suggested that CALNUC is associated primarily
with Golgi cisternae. To obtain further information on its
localization, we assessed CALNUC’s distribution in mem-
brane (100,000 g pellet) and cytosolic (100,000 g superna-
tant) fractions prepared from AtT-20, NRK, and REF-52
cells. In all cases, CALNUC was found in both membrane
and cytosolic fractions, with the percent detected in the
membrane fraction varying among different cell lines, i.e.,
90% in REF-52 cells, 80% in AtT-20 cells, and 50% in
NRK cells (Fig. 8). The CALNUC found in cytosolic frac-
tions could represent a true cytosolic pool or a soluble
pool released from the Golgi lumen during homogeniza-
tion. However, it seems unlikely that all the CALNUC
found in the cytosolic fraction could be released from the
Golgi lumen because in NRK cells only 30% of the Cab45,
a soluble luminal Golgi protein, was released into the cyto-
sol under the same conditions (data not shown). Further
study is required to clarify the relationship between the
CALNUC associated with Golgi membranes and that
found in cytosolic fractions.
The Membrane Pool of CALNUC Is Tightly Associated 
with Golgi Membranes and Faces the Golgi Lumen
The aa sequence of CALNUC contains a signal peptide
and lacks putative membrane-spanning domains suggest-
ing it is likely to be a soluble luminal protein or a periph-
eral membrane protein. To determine the topography of
the membrane-associated pool of CALNUC we digested
100,000 g pellets prepared from AtT-20 cells with protein-
ase K (PK). b-COP, a peripheral coat protein (Duden et al.,
1991) was completely digested by increasing amounts of
PK (Fig. 9), whereas CALNUC and calnexin (Fig. 9), an
integral membrane protein that faces the ER lumen
(Wada et al., 1991), were resistant to PK digestion, sug-
gesting that CALNUC is a luminal protein.
Next, AtT-20 cell membranes were subjected to alkaline
extraction (pH 11.5) with Na2CO3. As shown in Fig. 10 A,
most (90%) of the GM130, a Golgi-associated peripheral
membrane protein (Nakamura et al., 1995), was removed
but all of the calnexin, an ER integral membrane protein
(Wada et al., 1991), and most of the CALNUC remained
associated with the membrane pellet. When the time of al-
Figure 7. CALNUC is concentrated in cis-Golgi cisternae and the CGN in pituitary cells. (A and B) By immunogold labeling CALNUC
(10 nm gold) is concentrated in cis-Golgi cisternae and associated vesicles (arrowheads) in a secretory cell from the rat pituitary.
Counts of gold particles reveal that z80% of the gold is found on the 1–2 cis-most cisternae and associated vesicles of the CGN. Little
gold is found over ER (er), mitochondria (m) or secretion granules (sg). (C) Double immunogold labeling for CALNUC and TGN38 in
a cell from the rat pituitary. CALNUC (10 nm gold) is localized exclusively to cis-Golgi cisternae and associated vesicles. TGN38 (5 nm
gold) marks the TGN located on the opposite (trans) side of the Golgi stack. There is little or no overlap between the two. Preparation
and staining was the same as in Fig. 6 except that fixation was by perfusion with PLP fixative, and “C” was doubly stained for CALNUC
and TGN38 followed by gold-conjugated anti–rabbit and anti–mouse gold conjugates. Bar, 0.1 mm.The Journal of Cell Biology, Volume 141, 1998 1524
Figure 8. CALNUC is found
in both membrane and cyto-
solic fractions. Membrane
(M) and cytosolic (Cyt) frac-
tions were prepared by cen-
trifugation of PNS at 100,000 g
for 1 h. Membrane pellets
were resuspended in homogenization buffer to the same volume
as supernatants. 50-ml membrane or cystolic fractions were sepa-
rated by 10% SDS-PAGE and immunoblotted with affinity-puri-
fied rabbit anti-CALNUC. CALNUC (63 kD) is detected in both
membrane (M) and cytosolic (Cyt) fractions of all cell types
tested. The percent of the total CALNUC associated with mem-
brane fractions is 80% in AtT-20 cells (lane 2), 50% in NRK cells
(lane 4), and 90% in REF-52 cells (lane 6).
Figure 9. Membrane-associ-
ated CALNUC is a luminal
protein. Membranes (100,000
g pellet) prepared from AtT-
20 cells (see Fig. 8) were
treated with the indicated
concentrations of proteinase
K (PK) at room temperature
for 30 min in the presence
and absence of detergent fol-
lowed by immunoblotting
with polyclonal antibodies to
b-COP, calnexin, or CAL-
NUC. b-COP, a peripheral
coat protein, was completely
digested by 50 (lane 2) or 100
(lane 3) mg/ml PK whereas CALNUC (lanes 2, 3, 6, and 7) and
calnexin (lanes 6 and 7), a membrane protein that faces the ER
lumen, were resistant to PK digestion. In the presence of deter-
gent (1% Triton X-100) both CALNUC and calnexin were di-
gested (lanes 4 and 8).
kaline extraction was extended to 1 h, z10% of the CAL-
NUC was removed, but the majority (80–90%) remained
membrane associated (data not shown). When AtT-20 cell
membrane pellets were subjected to Triton X-114 extrac-
tion, CALNUC and a-adaptin, a peripheral membrane
protein (100 kD) facing the cytosol (Robinson, 1997),
were found entirely in the aqueous phase (Fig. 10 B). By
contrast most of the calnexin partitioned into the deter-
gent phase. These results together with the localization
studies suggest that CALNUC is a peripheral membrane
protein tightly associated with the luminal surface of Golgi
membranes.
CALNUC Is Enriched in Golgi Fractions of Rat Liver
To obtain further biochemical evidence for the association
of CALNUC with Golgi membranes, we carried out im-
munoblotting for CALNUC on Golgi fractions prepared
from rat liver by a procedure designed to separate Golgi
fractions from carrier vesicles and residual microsomes
(Saucan and Palade, 1994; Jin et al., 1996). Unlike in the
cultured cell lines, CALNUC was detected in membrane
fractions but not in cytosolic fractions even when up to 400
mg of cytosolic protein was loaded on the gels (data not
shown). As shown in Fig. 11 A, CALNUC was most en-
riched in the two Golgi fractions (GL and GH). To deter-
mine the topology of CALNUC, the GH fraction was
treated with PK in the presence or absence of detergent
(Fig. 11 B). CALNUC was resistant to PK digestion in the
absence of detergent, but was completely digested in the
presence of detergent as was Man II, a Golgi membrane
protein that faces the Golgi lumen. Rab6, a membrane an-
chored protein that faces the cytosol, was digested under
both conditions. When Golgi membranes were subjected
to alkaline extraction (pH 11.5), z80% of the CALNUC
was released into the supernatant (Fig. 11 C), but 20% re-
mained associated with Golgi membranes even after treat-
ment for up to 1 h. From these results we conclude that
CALNUC is a peripheral membrane protein tightly asso-
ciated with the luminal surface of Golgi membranes.
To establish whether CALNUC is a Golgi resident pro-
tein or a cargo protein in transit, we cleared rat hepato-
cytes of proteins in transit by treatment with cyclohexim-
ide for 90 min, using the procedure recently introduced to
distinguish endogenous Golgi proteins from cargo (Taylor
et al., 1997), followed by immunoblotting of Golgi frac-
tions for CALNUC. We found that CALNUC was readily
detected in Golgi fractions from cycloheximide (CHX)
treated rats at levels indistinguishable from controls (Fig.
12), thus demonstrating that CALNUC is a bona fide,
Golgi resident protein.
CALNUC Is a Major Calcium-binding Protein in
Golgi Fractions
To directly demonstrate that endogenous CALNUC asso-
ciated with Golgi membranes is capable of binding Ca21,
we carried out 45Ca21 overlays on pooled Golgi fractions.
We found that 45Ca21 bound to one major band at 63 kD
(Fig. 13, lane 2) that corresponded in mobility to CAL-
NUC (Fig. 13, lane 1). These results indicate that CAL-
NUC is the major Ca21-binding protein in Golgi fractions
as determined by 45Ca21 overlay.
Discussion
We have identified, characterized, and localized CALNUC,
an EF-hand, calcium-binding protein, and shown that it is a
resident protein of the CGN and cis-Golgi cisternae. CAL-
NUC corresponds to the rat homologue of a previously
identified mouse and human protein called nucleobindin, so
named because it bound to DNA in vitro (Miura et al.,
1992) and was thought to be located in the nucleus (Wang
et al., 1994). We demonstrate here that CALNUC is local-
ized to the Golgi region by immunofluorescence and that it
is concentrated in cis cisternae and/or the CGN by immuno-
electron microscopy in all tissues and cell lines examined.
We further found that CALNUC is a bona fide resident
Golgi protein as it is enriched in Golgi fractions prepared
from rat livers depleted of cargo. Moreover, we demon-
strated by 45Ca21 overlay that both recombinant CALNUC
(see Fig. 1) and endogenous CALNUC (see Fig. 13) are ca-
pable of binding Ca21. In fact, the only band detected in
Golgi fractions by 45Ca21 overlay was CALNUC.
Interestingly, CALNUC shows high homology to CRT
and has several properties in common with CRT in thatLin et al. GALNUC Is a Golgi Resident Protein 1525
both are Ca21-binding proteins (Miura et al., 1994; Baksh
and Michalak, 1996), both have been found to be secreted
in autoimmune diseases (Kanai et al., 1993; Sontheimer et al.,
1996), and both have been said to be localized to compart-
ments of the exocytic pathway (Opas, 1996; Krause and
Michalak, 1997). It is intriguing that CALNUC shows the
highest homology to the P- and C-domains of CRT that
are thought to represent, respectively, high affinity, low
capacity and high capacity, low affinity binding sites for
Ca21 (Baksh and Michalak, 1996). Besides its role in bind-
ing Ca21, CRT, as well as calnexin, has been shown to be a
glucose lectin that functions as an ER chaperone involved
in ER quality control by binding incompletely processed
proteins with exposed glucose groups (Parlati et al., 1996;
Helenius et al., 1997). However, neither the KPEDWD
motif found in both CRT and calnexin that binds integrins
(Krause and Michalak, 1997), nor the COOH-terminal
KDEL ER retention/retrieval signal is present in CAL-
NUC. We discovered that two motifs of unknown func-
tion, AY(I/A)EE and QRLX(Q/E)E(I/E)E, found in
CALNUC are shared with CRT. These regions may re-
flect the common role of those two proteins in binding
Ca21 or another, as yet undisclosed function.
A problem that remains unanswered is the significance
of CALNUC’s interaction with Ga subunits. CALNUC
has previously been shown to interact with Gai2 in the
yeast two-hybrid system (Mochizuki et al., 1995), and we
found here that it can interact with Gai3 and other mem-
bers of the Gai subfamily as well as Gs but not other Ga
subunits in the yeast two-hybrid system. We assume that
cytosolic CALNUC interacts with Ga subunits since Ga
subunits are mainly anchored through lipid anchors to the
cytoplasmic surface of membranes (Mumby, 1997). It
Figure 10. Characterization of
membrane-associated CALNUC.
(A) Alkaline extraction: mem-
branes prepared from AtT-20 cells
(see Fig. 8) were incubated with 0.2
M Na2CO3 (pH 11.5) for 30 min and
immunoblotted with antibodies
against CALNUC, calnexin or
GM130. Both CALNUC and cal-
nexin, an integral membrane pro-
tein, remained associated with the
membrane pellet (P), whereas
GM130, a peripheral membrane
protein, was released into the su-
pernatant. (B) Triton X-114 phase separation: AtT-20 cell membrane fractions were treated with 1% Triton X-114. After phase parti-
tioning, proteins in the aqueous (Aq) and detergent (D) phases were separated by SDS-PAGE and immunoblotted with the indicated
antibodies. CALNUC and a-adaptin, a peripheral coat protein, partitioned into the aqueous phase, whereas calnexin was found in the
detergent phase.
Figure 11. CALNUC is enriched in Golgi fractions from rat liver.
(A) CALNUC is detected mainly in Golgi light (GL) and Golgi
heavy (GH) fractions. CALNUC was not detected in cytosolic
(Cyt), carrier vesicle 2 (CV2), or residual microsome (RM) frac-
tions. A small amount was seen in CV1. Total microsomes (TM)
were adjusted to 1.24 M sucrose, loaded onto the bottom of a dis-
continuous sucrose gradient and centrifuged at 82,000 g for 1 h.
Fractions were collected, and 50 mg protein from each was sepa-
rated by SDS-PAGE and immunoblotted with affinity-purified
anti-CALNUC IgG. (B) CALNUC is resistant to proteinase K
(PK) digestion. Rab6, a membrane anchored protein facing the
cytoplasm was digested, whereas CALNUC and Man II, a mem-
brane protein facing the Golgi lumen, were protected from PK
digestion. In the presence of detergent (Triton X-100) both Man
II and CALNUC were digested. (C) Alkaline extraction: when
Golgi membranes (GL and GH) were treated with 200 mM
Na2CO3,  z80% of the CALNUC was released into the superna-
tant (S) and the remainder remained associated with the mem-
brane pellet (P). Rab6, a membrane-anchored protein, was not
released, and all of the GM130, a Golgi peripheral membrane
protein, was released into the supernatant after this treatment.
Figure 12. Membrane-asso-
ciated CALNUC is a Golgi
resident protein. 100 mg each
of Golgi fractions S-I (light-
est fraction, lane 1), S-II
(lane  2), and S-III (heaviest
fraction, lane 3) obtained
from livers of rats treated
with CHX (lanes 1–3) for 90
min or pooled Golgi frac-
tions from controls (lane 4)
were separated by SDS-
PAGE and immunoblotted for CALNUC as described in Materi-
als and Methods. Endogenous CALNUC can be identified as a
63-kD band in both controls and Golgi fractions depleted of pro-
teins in transit by CHX treatment.The Journal of Cell Biology, Volume 141, 1998 1526
seems unlikely that the Golgi luminal pool would have the
opportunity to bind Ga subunits as CALNUC and Ga
subunits are on opposite sides of membranes. In this paper
we focused on characterization of the luminal, Golgi mem-
brane–associated pool of CALNUC, but the relationship
between soluble and membrane-associated CALNUC and
the interaction of CALNUC with Ga subunits remain in-
triguing problems for the future.
Another unanswered problem is how the membrane
pool of CALNUC is bound to the luminal surface of Golgi
membranes. In cultured cells we found that CALNUC has
a pI of 4.9 by isoelectric focusing (our unpublished obser-
vation), is tightly anchored to Golgi membranes and can-
not be extracted by extended alkaline treatment. CAL-
NUC lacks a putative transmembrane domain and is likely
to represent a peripheral membrane protein which, like
p62 (Jones et al., 1993), is so tightly bound to one or more
Golgi proteins that it cannot be readily extracted by high
pH treatment. However, we cannot rule out that CAL-
NUC could be anchored by a lipid anchor such as palmi-
tate or by a 15-aa hydrophobic region found at its COOH
terminus. In the case of synaptobrevin and other SNARES
it has been shown that 12 hydrophobic aa at the COOH
terminus is sufficient for membrane anchoring (Kutay et
al., 1993; Whitley et al., 1996).
CALNUC is only the second Golgi calcium-binding pro-
tein identified to date, with Cab45 being the first (Scherer
et al., 1996). Cab45 differs from CALNUC in that it is a
soluble Golgi resident protein found in the Golgi lumen
and is completely extracted after high pH treatment. It
also has a putative glycosylation site that is lacking in
CALNUC.
What is the role of calcium-binding proteins in the
Golgi? It has recently been shown that high level of Ca21
in the Golgi is comparable to that of the ER and is seen all
across the stacked cisternae, cis to trans (Pezzati et al.,
1997). Surprisingly, the concentration in the TGN is some-
what lower. We can speculate, based on studies on the ER,
that Ca21-binding to CALNUC can serve one of two func-
tions: (a) It may serve to maintain the high calcium levels
required for Golgi functions such as sorting, lectin binding,
and concentration of cargo into regulated secretory gran-
ules, or (b) binding of Ca21 may cause conformational
changes in CALNUC that render it competent for specific,
as yet unknown interactions. In addition, it is possible that
CALNUC may bind other divalent cations. CRT has been
shown to bind zinc and iron as well as calcium (Baksh and
Michalak, 1996). Specific Golgi functions may have spe-
cific divalent cation requirements. For example, it has
been shown that UDP-GalNAc:polypeptide N-acetylga-
lactosamine transferase, the enzyme that adds the initial
galactose to mucin-type glycoproteins, requires Mn21 both
in vitro (Sugiura et al., 1982) and in vivo (Kaufman et al.,
1994).
This study opens a number of new and intriguing ques-
tions concerning the functions of CALNUC in Ca21 ho-
meostasis in the Golgi, the requirements for Ca21 for
Golgi functions, and whether heterotrimeric G proteins
are involved in Ca21 homeostasis in the Golgi.
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